Want to see NDRA full AI Analyst Report?
ENDRA Life Sciences (NDRA) Financial Statements
861 Followers
ENDRA Life Sciences Financial Overview
ENDRA Life Sciences's market cap is currently $7.29M. The company's EPS TTM is $-6.33; its P/E ratio is -0.78; ENDRA Life Sciences is estimated to report earnings on November 16, 2026, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -5.76M | $ -10.82M | $ -10.52M | $ -13.16M | $ -11.50M |
| EBITDA | $ -6.87M | $ -11.30M | $ -9.78M | $ -12.92M | $ -11.01M |
| Net Income | $ -7.03M | $ -11.51M | $ -10.06M | $ -13.18M | $ -11.23M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 762.37K | $ 3.23M | $ 2.83M | $ 4.89M | $ 9.46M |
| Total Assets | $ 3.85M | $ 4.45M | $ 6.75M | $ 9.27M | $ 12.87M |
| Total Debt | $ 492.35K | $ 754.14K | $ 394.40K | $ 546.63K | $ 796.09K |
| Net Debt | $ -270.01K | $ -2.48M | $ -2.44M | $ -4.34M | $ -8.67M |
| Total Liabilities | $ 1.59M | $ 1.89M | $ 1.10M | $ 2.07M | $ 2.09M |
| Stockholders' Equity | $ 2.26M | $ 2.56M | $ 5.66M | $ 7.20M | $ 10.78M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.20M | $ -7.42M | $ -9.58M | $ -12.97M | $ -11.17M |
| Operating Cash Flow | $ -5.18M | $ -7.40M | $ -9.55M | $ -12.77M | $ -11.12M |
| Investing Cash Flow | $ -3.02M | $ -12.80K | $ -24.72K | $ -202.58K | $ -45.00K |
| Financing Cash Flow | $ 5.73M | $ 7.81M | $ 7.52M | $ 8.40M | $ 13.40M |
Currency in USD
